BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31800492)

  • 1. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
    Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
    Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
    Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Pukkala E; Romundstad P; Tryggvadóttir L; Euler-Chelpin MV; Lagergren J
    Ann Surg; 2022 Aug; 276(2):e79-e85. PubMed ID: 33074906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
    Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
    Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
    Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
    Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
    Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
    Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
    JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study.
    Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Nwaru B; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    Eur J Cancer; 2020 Oct; 138():80-88. PubMed ID: 32877797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.
    Markar SR; Arhi C; Wiggins T; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
    Ann Surg; 2020 Apr; 271(4):709-715. PubMed ID: 30499807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
    Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
    Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
    Bakr O; Zhao W; Corley D
    J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
    Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
    Rubenstein JH; Scheiman JM; Sadeghi S; Whiteman D; Inadomi JM
    Am J Gastroenterol; 2011 Feb; 106(2):254-60. PubMed ID: 21139576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of esophageal adenocarcinoma after antireflux surgery.
    Lagergren J; Ye W; Lagergren P; Lu Y
    Gastroenterology; 2010 Apr; 138(4):1297-301. PubMed ID: 20080091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study.
    Maret-Ouda J; Tao W; Mattsson F; Brusselaers N; El-Serag HB; Lagergren J
    Surg Obes Relat Dis; 2017 Jan; 13(1):28-34. PubMed ID: 26723560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
    Ye W; Chow WH; Lagergren J; Yin L; Nyrén O
    Gastroenterology; 2001 Dec; 121(6):1286-93. PubMed ID: 11729107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study.
    Yanes M; Santoni G; Maret-Ouda J; Markar S; Ness-Jensen E; Kauppila J; Färkkilä M; Lynge E; Pukkala E; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
    Gastroenterology; 2021 Jun; 160(7):2283-2290. PubMed ID: 33587926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.